by Extivita | Mar 22, 2015 | Cancer
Abstract: Osteoradionecrosis (ORN) of the temporal bone is a complication of radiation therapy that is extremely challenging to manage. We report the case of a patient treated at our institution and present a review of the literature. A 52-year-old woman presented...
by Extivita | Jan 6, 2015 | Myeloma
Abstract: Osteonecrosis of the jaw (ONJ) is a serious side effect of bisphosphonate use in patients with osteoporosis, Paget’s disease, hypercalcemia of malignancy, metastatic bone disease and multiple myeloma, although recently this complication has also been...
by Extivita | Dec 22, 2011 | Myeloma
Abstract: This study tested hyperbaric oxygen (HBO) as an adjunct to surgery and antibiotics in the treatment of bisphosphonate-related osteonecrosis of the jaw (ONJ) and evaluated its effects on gingival healing, pain, and quality of life. The investigators...
by Extivita | Jun 5, 2010 | Carcinoma
Abstract: Osteonecrosis of the jaw (ONJ) is recognised as an important adverse effect of intravenous bisphosphonates. Recent reports have suggested that antiangiogenic agents may promote the development of this condition. We report a case of ONJ occurring within days...
by Extivita | Oct 2, 2009 | Cancer
Abstract: We describe a patient who developed bisphosphonate (BP)-related osteonecrosis of the jaw (ONJ) around implants in the upper molar area. The patient was a 54-year-old woman with ulceration of the gum, bone exposure, and severe spontaneous pain around implants...